Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Single-cell ATAC and RNA sequencing reveal pre-existing and persistent cells associated with prostate cancer relapse.
Nat Commun. 2021 Sep 6;12(1):5307. doi: 10.1038/s41467-021-25624-1.
Nat Commun. 2021.
PMID: 34489465
Free PMC article.
Single cell characterization of B-lymphoid differentiation and leukemic cell states during chemotherapy in ETV6-RUNX1-positive pediatric leukemia identifies drug-targetable transcription factor activities.
Mehtonen J, Teppo S, Lahnalampi M, Kokko A, Kaukonen R, Oksa L, Bouvy-Liivrand M, Malyukova A, Mäkinen A, Laukkanen S, Mäkinen PI, Rounioja S, Ruusuvuori P, Sangfelt O, Lund R, Lönnberg T, Lohi O, Heinäniemi M.
Mehtonen J, et al. Among authors: lahnalampi m.
Genome Med. 2020 Nov 20;12(1):99. doi: 10.1186/s13073-020-00799-2.
Genome Med. 2020.
PMID: 33218352
Free PMC article.
Item in Clipboard
Time-resolved expression profiling of the nuclear receptor superfamily in human adipogenesis.
Lahnalampi M, Heinäniemi M, Sinkkonen L, Wabitsch M, Carlberg C.
Lahnalampi M, et al.
PLoS One. 2010 Sep 27;5(9):e12991. doi: 10.1371/journal.pone.0012991.
PLoS One. 2010.
PMID: 20885999
Free PMC article.
Item in Clipboard
SIX6 is a TAL1-regulated transcription factor in T-ALL and associated with inferior outcome.
Laukkanen S, Oksa L, Nikkilä A, Lahnalampi M, Parikka M, Seki M, Takita J, Degerman S, de Bock CE, Heinäniemi M, Lohi O.
Laukkanen S, et al. Among authors: lahnalampi m.
Leuk Lymphoma. 2020 Dec;61(13):3089-3100. doi: 10.1080/10428194.2020.1804560. Epub 2020 Aug 24.
Leuk Lymphoma. 2020.
PMID: 32835548
Item in Clipboard
Sequential drug treatment targeting cell cycle and cell fate regulatory programs blocks non-genetic cancer evolution in acute lymphoblastic leukemia.
Malyukova A, Lahnalampi M, Falqués-Costa T, Pölönen P, Sipola M, Mehtonen J, Teppo S, Akopyan K, Viiliainen J, Lohi O, Hagström-Andersson AK, Heinäniemi M, Sangfelt O.
Malyukova A, et al. Among authors: lahnalampi m.
Genome Biol. 2024 May 31;25(1):143. doi: 10.1186/s13059-024-03260-4.
Genome Biol. 2024.
PMID: 38822412
Free PMC article.
Item in Clipboard
Development of combination therapies with BTK inhibitors and dasatinib to treat CNS-infiltrating E2A-PBX1+/preBCR+ ALL.
Gentile G, Poggio T, Catalano A, Voutilainen M, Lahnalampi M, Andrade-Martinez M, Ma T, Sankowski R, Goncharenko L, Tholen S, Han K, Morgens DW, Prinz M, Lübbert M, Engel S, Hartmann TN, Cario G, Schrappe M, Lenk L, Stanulla M, Duyster J, Bronsert P, Bassik MC, Cleary ML, Schilling O, Heinäniemi M, Duque-Afonso J.
Gentile G, et al. Among authors: lahnalampi m.
Blood Adv. 2024 Jun 11;8(11):2846-2860. doi: 10.1182/bloodadvances.2023011582.
Blood Adv. 2024.
PMID: 38598725
Item in Clipboard
In vivo interrogation of regulatory genomes reveals extensive quasi-insufficiency in cancer evolution.
Fischer A, Lersch R, de Andrade Krätzig N, Strong A, Friedrich MJ, Weber J, Engleitner T, Öllinger R, Yen HY, Kohlhofer U, Gonzalez-Menendez I, Sailer D, Kogan L, Lahnalampi M, Laukkanen S, Kaltenbacher T, Klement C, Rezaei M, Ammon T, Montero JJ, Schneider G, Mayerle J, Heikenwälder M, Schmidt-Supprian M, Quintanilla-Martinez L, Steiger K, Liu P, Cadiñanos J, Vassiliou GS, Saur D, Lohi O, Heinäniemi M, Conte N, Bradley A, Rad L, Rad R.
Fischer A, et al. Among authors: lahnalampi m.
Cell Genom. 2023 Mar 8;3(3):100276. doi: 10.1016/j.xgen.2023.100276. eCollection 2023 Mar 8.
Cell Genom. 2023.
PMID: 36950387
Free PMC article.
Item in Clipboard
Cite
Cite